miR-130a-3p, a Preclinical Therapeutic Target for Crohn’s Disease
Jie Zhao(Kunming Institute of Zoology), Weiming Zhu(Southeast University), Liming Tang(Changzhou No.2 People's Hospital), Yan Zhou(Second Military Medical University), Pu Ying(Model Animal Research Center), Yu Gong(Soochow University), Xiaoyang Qi(Changzhou No.2 People's Hospital), Jun Qian(Hefei University of Technology), Ye Sun(Jiangsu Province Hospital), Hao Ding(Liaocheng People's Hospital), Haojun Yang(Nanjing Medical University), Jin Zhou(Soochow University), Hong-Gang Wang(Tongji University), Yuwen Jiao(Changzhou No.2 People's Hospital)
Cited by 17
Related Papers
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
|Molecular Neurodegeneration|2016|450
Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain
|Neuroscience Letters|2010|178
Ultrasound as a diagnostic tool in detecting active Crohn’s disease: a meta-analysis of prospective studies
|European Radiology|2013|124
Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo
|International Journal of Oncology|2017|116
Caffeine induces sustained apoptosis of human gastric cancer cells by activating the caspase-9/caspase-3 signalling pathway
|Molecular Medicine Reports|2017|76